It has been demonstrated that activated CD8+HLA-DR+CD38+ T cells in a mild case of COVID-19 significantly expand following symptom onset, which reached their peak frequency of 12% of CD8+ T cells on day 9 after symptom onset and contracted thereafter [52]. This evidence concerns the gene CD38 and COVID-19.